Cyril QUIVORON

En résumé

Entreprises

• Gustave Roussy - Research Engineer

  Villejuif 2012 - maintenant IDH mutations as therapeutic targets in acute myeloid leukemia.

Formations

• PHD Student (Gustave Roussy

  Gustave Roussy (U985) 2008 - 2012 TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis.
  Quivoron et al., Cancer Cell, 2011.

Réseau

• Koichi NAKABAYASHI

• Xénia CABAGNOLS